Safety concerns of sodium-glucose co-transporter-2 inhibitors in type 1 diabetes: A real-world study from the perspective of the Food and Drug Administration Adverse Event Reporting System.

Szczegóły
Comments

Tytuł:: Safety concerns of sodium-glucose co-transporter-2 inhibitors in type 1 diabetes: A real-world study from the perspective of the Food and Drug Administration Adverse Event Reporting System.
Autorzy:: Zhou X; Department of Endocrinology, Key Laboratory of Endocrinology of National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Zhou Y; Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Li X; Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Xiao X; Department of Endocrinology, Key Laboratory of Endocrinology of National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Źródło:: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Nov; Vol. 22 (11), pp. 2204-2206. Date of Electronic Publication: 2020 Aug 07.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't; Comment
Język:: English
Imprint Name(s):: Original Publication: Oxford : Wiley-Blackwell, c1999-
MeSH Terms:: Diabetes Mellitus, Type 1*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Symporters*
Glucose ; Humans ; Hypoglycemic Agents/adverse effects ; Sodium ; United States/epidemiology ; United States Food and Drug Administration
Grant Information:: 81570715 International National Natural Science Foundation of China; 81870579 International National Natural Science Foundation of China
Substance Nomenclature:: 0 (Hypoglycemic Agents)
0 (Sodium-Glucose Transporter 2 Inhibitors)
0 (Symporters)
9NEZ333N27 (Sodium)
IY9XDZ35W2 (Glucose)
Entry Date(s):: Date Created: 20200708 Date Completed: 20210127 Latest Revision: 20210127
Update Code:: 20240105
DOI:: 10.1111/dom.14138
PMID:: 32633000
: Raport

Full Text Finder

Comment on: Diabetes Obes Metab. 2020 Oct;22(10):1767-1776. (PMID: 32436630)

Informacja